BrainStorm Cell Therapeutics Expands Pipeline with the Initiation of a Study for Multiple Sclerosis

Proposed Trial Will Build on NurOwn(TM) Platform to Meet Unmet Needs of Patients with Neurodegenerative Disorders.

NEW YORK & PETACH TIKVAH, ISRAEL, Mar 13, 2012 -- BrainStorm Cell Therapeutics Inc., a developer of adult stem cell technologies and CNS therapeutics, announces plans to initiate a preclinical study assessing the efficacy of its NurOwn(TM) stem cell technology in patients with Multiple Sclerosis (MS). Positive proof-of-concept results for MS have been confirmed in a set of in-vitro and in-vivo experiments, and the Company is working to advance MS into preclinical development in Q2 2012.

Based on initial promising pre-clinical data published by the Company's Chief Scientist, Prof. Daniel Offen of Tel Aviv University, BrainStorm has decided to explore MS as an additional indication for its NurOwn technology. The Company will draw plans to initiate pre-clinical safety trials, after which it will seek a leading medical center specializing in MS for clinical trials.

"We have been focused on growing our pipeline of indications using our NurOwn(TM) stem-cell technology," commented Dr. Adrian Harel, Acting CEO of BrainStorm Cell Therapeutics. "As we continue our ongoing trials to evaluate the safety, tolerability and therapeutic effects of NurOwn(TM) in ALS patients, we have determined through positive preliminary animal data that MS will be the next indication to pursue using our technology."

About NurOwn(TM) BrainStorm's core technology, NurOwn(TM), is based on the scientific achievements of Professor Eldad Melamed, former Head of Neurology, Rabin Medical Center, and Tel-Aviv University, and Professor Daniel Offen, Head of the Neuroscience Laboratory, Felsenstein Medical Research Center at the Tel-Aviv University.

The NurOwn(TM) technology processes adult human mesenchymal stem cells that are present in bone marrow and are capable of self-renewal as well as differentiation into many cell types. The research team is among the first to have successfully achieved the in-vitro differentiation of adult bone marrow cells (animal and human) into cells capable of releasing neurotrophic factors, such as glial-derived neurotrophic factor (GDNF), by means of a specific differentiation-inducing culture medium.

About Multiple Sclerosis (MS)
Multiple sclerosis (MS) is believed to be an autoimmune disorder that affects the central nervous system (CNS). Autoimmune means that the body's immune system mistakenly attacks its own tissue, in this case, the tissues of the CNS. With MS, autoimmune damage to neurons disrupts the body's ability to send and receive signals, thus causing MS-related symptoms.Symptoms may vary due to the location and extent of the damage. Worldwide, MS may affect more than 2 million individuals, including approximately 400,000 people in the United States.

About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of adult stem cell therapeutic products derived from autologous bone marrow cells and intended for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwn(TM) technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel-Aviv University. For more information, visit the company's website at

Media Contact:
Janet Vasquez
1251 Avenue of the Americas, 20th Floor
New York, NY 10020

Rosendin Electric Names Jonas McBride to New Role as Director, Central U.S. Engineering

New Position Expands Engineering and Design Capabilities in Central U.S. Market.

AUSTIN, Texas (March 13, 2012) -- Rosendin Electric (, one of the nation’s largest private electrical contractors and a 100% employee-owned company, has named Jonas McBride to the newly created role of Director, Central U.S. Engineering, to help oversee multi-office engineering projects and expand Rosendin Electric’s operations in the central United States. McBride will be based in Austin, Texas at the offices of KST Electric, a wholly-owned subsidiary of Rosendin Electric.

In his new role, McBride will be responsible for overseeing Rosendin Electric’s engineering practice throughout the central United States, including managing engineering teams, supporting business development and new contract bids, managing design/build services, and establishing engineering best practices. McBride will report to Ron Wilson, Director of Engineering at Rosendin Electric headquarters in San Jose, California.

McBride brings 17 years of experience in design and construction of large, complex, multi-phased facilities to Rosendin Electric. He has managed engineering projects across a diverse range of industries, including mission-critical, healthcare, biotech/pharmaceutical, commercial, retail, education, and government facilities. McBride will also be responsible for managing the Texas-based engineering team and working with the company’s contracting partners.

Adding Jonas to our team will help us expand our engineering and design/build capabilities across the central states,” said Wilson. “We have especially seen a need to support growth in the Texas market with a number of new data center, healthcare, and commercial construction projects. The creation of this new role of Director of Central U.S. Engineering will help us consolidate our engineering expertise, deliver better client service, and work more efficiently with our contractor partners.”

Before joining Rosendin Electric, McBride was a consultant specializing in mission-critical data center design. He also has worked for Smith Seckman Reid, Inc., NSPOF Communications, and Day Brown Rice, Inc. He holds a Bachelor of Science degree in Architectural Engineering from Kansas State University.

About Rosendin Electric
Rosendin Electric, Inc., headquartered in San Jose, California, is a 100% employee-owned electrical engineering, power and communications provider and is one of the largest privately held electrical contractors in the United States. With over 2,500 employees, Rosendin Electric has offices and experience nationwide and has built upon a 90-year reputation for quality design and installations. For additional information, visit

Shelly Goulart
Marketing Manager
Rosendin Electric
880 Mabury Road
San Jose, CA 95133
(408) 534-2819

Brazil is a great place to invest, claims AAA

The news that the Brazilian economy has started to outperform many others, including the UK’s, has acted as a prompt for many to start looking for ways to invest in the growing country, according to AAA.

Boston, MA, USA, March 13, 2012 -- The news that the Brazilian economy has started to outperform many others, including the UK’s, has acted as a prompt for many to start looking for ways to invest in the growing country, according to Alternative Asset Analysis (AAA).

AAA, an alternative investment advocacy firm, has always seen Brazil as a great place to invest in commodities, such as timber, and in ethical and social funds, through impact investing routes. However, the world is expected to start investing cash in Brazil in droves thanks to the latest figures from the Centre for Economics and Business Research (CEBR).

Over the past ten years, the emerging economies of Brazil, Russia, India and China, otherwise known as the BRIC region, have offered a comparatively safe haven for investors keen to avoid investing in the volatile markets in the US and Europe.

Now, the figures show that this is even more the case as Brazil’s economy is officially the sixth largest in the world, leaving the UK in its wake. Analyst at the CEBR claim that within a few years, Brazil’s economy will be stronger than that of France and Germany, climbing further up the ranking of the world’s great economic super powers.

Although last year’s 2.7 per cent growth wasn't enormous, in the grand scale of things, Brazil continues to grow economically when many other top economies are still teetering on the edge of recession” explained AAA’s analysis partner, Anthony Johnson.

He added, “There has rarely been a better time to invest in emerging economies and investors who want to diversify their portfolios could not do better than investing in sustainable forestry in Brazil.

We support the plantation projects bin run by firms like Greenwood Management, who are offering a unique and low-entry route into Brazilian investment, with an ethical edge.”

About Alternative Asset Analysis:
The remit of Alternative Asset Analysis is to analyse and provide news on the global performance of a wide range of alternative asset classes including, but not restricted to, commodities, real estate, forestry, foreign exchange, hedge funds, private equity and venture capital.

Media Contact:
Anthony Johnson
Alternative Asset Analysis
71 Commercial St
Boston, MA 02109-1320